Ventyx Biosciences earnings were -$135.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest VTYX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$29.4M, down 16.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VTYX reported annual earnings of -$135.1M, with -30% growth. The next VTYX earnings date is Jun 5, 2025.
What were Ventyx Biosciences's earnings last quarter?
Ventyx Biosciences (NASDAQ: VTYX) reported Q4 2024 earnings per share (EPS) of -$0.41, up 48.1% year over year. Total VTYX earnings for the quarter were -$29.35 million. In the same quarter last year, Ventyx Biosciences's earnings per share (EPS) was -$0.79.
The next VTYX earnings date is Invalid Date. Add VTYX to your watchlist to be reminded of Ventyx Biosciences's next earnings date.
Is Ventyx Biosciences profitable or losing money?
As of the last Ventyx Biosciences earnings report, Ventyx Biosciences is currently losing money. Ventyx Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$135.12 million, a 29.97% decrease year over year.
What was VTYX's earnings growth in the past year?
As of Ventyx Biosciences's earnings date in Q2 2025, Ventyx Biosciences's earnings has grown year over year. VTYX earnings in the past year totalled -$135.12 million.
What are Ventyx Biosciences's earnings expectations?
The current EPS estimate for Ventyx Biosciences's earnings report in Invalid Date is -$0.69.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.